CAPITOL HILL CONSULTING GROUP for ENDO PHARMACEUTICALS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 19, 2015 | $50,000 | Replaced |
| 3rd Quarter - Amendment | Jan 24, 2018 | $50,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| BILL K BREWSTER | — |
| DAVID JORY | — |
| BRIAN SUTTER New | Staff Dir., W&M Health Subcommittee, Chrman Dave Camp April'13-Dec.'14 Professional Staff, W&M Health Subcommittee, Chrman Dave Camp, Jan'11-April'13 Leg Dir. Rep. Dave Camp, May'08-Jan'11 Leg Asst Rep. Dave Camp, Feb'03-May'08; Staff Ast July'02- |
Taxation/Internal Revenue Code TAX
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| BILL K BREWSTER | — |
| DAVID JORY | — |
| BRIAN SUTTER New | Staff Dir., W&M Health Subcommittee, Chrman Dave Camp April'13-Dec.'14 Professional Staff, W&M Health Subcommittee, Chrman Dave Camp, Jan'11-April'13 Leg Dir. Rep. Dave Camp, May'08-Jan'11 Leg Asst Rep. Dave Camp, Feb'03-May'08; Staff Ast July'02- |
Health Issues HCR
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| BILL K BREWSTER | — |
| DAVID JORY | — |
| BRIAN SUTTER New | Staff Dir., W&M Health Subcommittee, Chrman Dave Camp April'13-Dec.'14 Professional Staff, W&M Health Subcommittee, Chrman Dave Camp, Jan'11-April'13 Leg Dir. Rep. Dave Camp, May'08-Jan'11 Leg Asst Rep. Dave Camp, Feb'03-May'08; Staff Ast July'02 |
Pharmacy PHA
Issues related to tamper resistant formulation of pharmaceutical and generic drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| BILL K BREWSTER | — |
| DAVID JORY | — |
| BRIAN SUTTER New | Staff Dir., W&M Health Subcommittee, Chrman Dave Camp April'13-Dec.'14 Professional Staff, W&M Health Subcommittee, Chrman Dave Camp, Jan'11-April'13 Leg Dir. Rep. Dave Camp, May'08-Jan'11 Leg Asst Rep. Dave Camp, Feb'03-May'08; Staff Ast July'02 |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.